Taking place at the European Academy of Allergy and Clinical Immunology (EAACI) Digital Congress 2020, the Sanofi Genzyme and Regeneron sponsored ADVENT medical education symposium: “Type 2 Inflammation in Atopic Dermatitis and Beyond: Shared Pathophysiology and Clinical Management” linked the science of type 2 inflammation to clinical management and facilitated a lively discussion on the advances in type 2 inflammatory diseases.
EMJ Allergy & Immunology 5 [Supplement 1] . 2020
August 2020
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given